Skip to main content
An official website of the United States government

Funded Symptom Science Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Flory, James H

Sloan-Kettering Inst Can Research
United States

Managing metabolic disruption in pancreatic cancer to prevent weight loss and improve quality of life 5R21CA277464-02 Gabriela Riscuta, M.D., CNS
Flory, James H

Sloan-Kettering Inst Can Research
United States

Managing metabolic disruption in pancreatic cancer to prevent weight loss and improve quality of life 5R21CA277464-02 Gabriela Riscuta, M.D., CNS
Flynn, Kathryn E

Medical College Of Wisconsin
United States

Symptom Monitoring using Patient-Reported Outcomes to Optimize Medication Use (SyMPTOM) 1R01CA285925-01A1
Flynn, Kathryn E

Medical College Of Wisconsin
United States

Symptom Monitoring using Patient-Reported Outcomes to Optimize Medication Use (SyMPTOM) 1R01CA285925-01A1
Friday, Bret E.B.

Essentia Institute Of Rural Health
United States

Essentia Health Community Cancer Research Program - NCORP 3UG1CA189812-11S1 Vanessa A. White, M.P.H.
Friday, Bret E.B.

Essentia Institute Of Rural Health
United States

Essentia Health Community Cancer Research Program - NCORP 3UG1CA189812-11S1 Vanessa A. White, M.P.H.
Garcia, Jose M.

Seattle Inst For Biomedical/Clinical Res
United States

SArcopenia in Men with Prostate Cancer undergoing ADT (SAP-ADT) 5R01CA279220-02 Marjorie Perloff, M.D.
Garcia, Jose M.

Seattle Inst For Biomedical/Clinical Res
United States

SArcopenia in Men with Prostate Cancer undergoing ADT (SAP-ADT) 5R01CA279220-02 Marjorie Perloff, M.D.
Geisler, Stefanie

Washington University
United States

Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy 5R37CA267905-04 Asad Umar, D.V.M., Ph.D.
Geisler, Stefanie

Washington University
United States

Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy 5R37CA267905-04 Asad Umar, D.V.M., Ph.D.
Gill, Brian John Andrew

Columbia University Health Sciences
United States

The Impact of Local and Reversible Change to GABAergic Inhibitory Signaling on Tumor-Induced Cortical Dysfunction in Glioma 1R01NS140658-01A1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Gill, Brian John Andrew

Columbia University Health Sciences
United States

The Impact of Local and Reversible Change to GABAergic Inhibitory Signaling on Tumor-Induced Cortical Dysfunction in Glioma 1R01NS140658-01A1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Gonzalez, Brian D

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Impact of Targeted Therapy on Cancer-Related Cognitive Impairment 1R01CA287666-01A1
Gonzalez, Brian D

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Impact of Targeted Therapy on Cancer-Related Cognitive Impairment 1R01CA287666-01A1
Goode, Diana J

University Of New England
United States

Novel expression of MHC class II on DRG neurons and its role in promoting antinociceptive CD4+ T cells in females during chemotherapy-induced peripheral neuropathy 5R01CA267554-04 Rachel Altshuler, Ph.D.